Global Drug Repositioning Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Drug Repositioning market size was valued at USD 27030 million in 2023 and is forecast to a readjusted size of USD 36780 million by 2030 with a CAGR of 4.5% during review period.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
The Global Info Research report includes an overview of the development of the Drug Repositioning industry chain, the market status of Cardiovascular Diseases (Generic Drugs, Clinical Trial Failed Drugs), Mental Illness (Generic Drugs, Clinical Trial Failed Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Repositioning.
Regionally, the report analyzes the Drug Repositioning markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Repositioning market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Repositioning market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Repositioning industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Repositioning market.
Regional Analysis: The report involves examining the Drug Repositioning market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Repositioning market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Repositioning:
Company Analysis: Report covers individual Drug Repositioning players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Repositioning This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular Diseases, Mental Illness).
Technology Analysis: Report covers specific technologies relevant to Drug Repositioning. It assesses the current state, advancements, and potential future developments in Drug Repositioning areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Repositioning market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug Repositioning market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Drug Repositioning product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Repositioning, with revenue, gross margin and global market share of Drug Repositioning from 2019 to 2024.
Chapter 3, the Drug Repositioning competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Repositioning market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Repositioning.
Chapter 13, to describe Drug Repositioning research findings and conclusion.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
The Global Info Research report includes an overview of the development of the Drug Repositioning industry chain, the market status of Cardiovascular Diseases (Generic Drugs, Clinical Trial Failed Drugs), Mental Illness (Generic Drugs, Clinical Trial Failed Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Repositioning.
Regionally, the report analyzes the Drug Repositioning markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Repositioning market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Repositioning market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Repositioning industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Repositioning market.
Regional Analysis: The report involves examining the Drug Repositioning market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Repositioning market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Repositioning:
Company Analysis: Report covers individual Drug Repositioning players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Repositioning This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular Diseases, Mental Illness).
Technology Analysis: Report covers specific technologies relevant to Drug Repositioning. It assesses the current state, advancements, and potential future developments in Drug Repositioning areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Repositioning market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug Repositioning market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Generic Drugs
- Clinical Trial Failed Drugs
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Others
- Teva
- Novartis
- Mylan
- Johnson & Johnson
- Pfizer
- Bausch Health
- GSK
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Drug Repositioning product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Repositioning, with revenue, gross margin and global market share of Drug Repositioning from 2019 to 2024.
Chapter 3, the Drug Repositioning competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Repositioning market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Repositioning.
Chapter 13, to describe Drug Repositioning research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Drug Repositioning
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Repositioning by Type
1.3.1 Overview: Global Drug Repositioning Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Drug Repositioning Consumption Value Market Share by Type in 2023
1.3.3 Generic Drugs
1.3.4 Clinical Trial Failed Drugs
1.4 Global Drug Repositioning Market by Application
1.4.1 Overview: Global Drug Repositioning Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cardiovascular Diseases
1.4.3 Mental Illness
1.4.4 Cancer
1.4.5 Others
1.5 Global Drug Repositioning Market Size & Forecast
1.6 Global Drug Repositioning Market Size and Forecast by Region
1.6.1 Global Drug Repositioning Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Drug Repositioning Market Size by Region, (2019-2030)
1.6.3 North America Drug Repositioning Market Size and Prospect (2019-2030)
1.6.4 Europe Drug Repositioning Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Drug Repositioning Market Size and Prospect (2019-2030)
1.6.6 South America Drug Repositioning Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Drug Repositioning Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Drug Repositioning Product and Solutions
2.1.4 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Teva Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Drug Repositioning Product and Solutions
2.2.4 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Drug Repositioning Product and Solutions
2.3.4 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Drug Repositioning Product and Solutions
2.4.4 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Drug Repositioning Product and Solutions
2.5.4 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Drug Repositioning Product and Solutions
2.6.4 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bausch Health Recent Developments and Future Plans
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Drug Repositioning Product and Solutions
2.7.4 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSK Recent Developments and Future Plans
2.8 ChemRar Group
2.8.1 ChemRar Group Details
2.8.2 ChemRar Group Major Business
2.8.3 ChemRar Group Drug Repositioning Product and Solutions
2.8.4 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ChemRar Group Recent Developments and Future Plans
2.9 Glenmark
2.9.1 Glenmark Details
2.9.2 Glenmark Major Business
2.9.3 Glenmark Drug Repositioning Product and Solutions
2.9.4 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Glenmark Recent Developments and Future Plans
2.10 Fujifilm
2.10.1 Fujifilm Details
2.10.2 Fujifilm Major Business
2.10.3 Fujifilm Drug Repositioning Product and Solutions
2.10.4 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fujifilm Recent Developments and Future Plans
2.11 Dr. Reddy
2.11.1 Dr. Reddy Details
2.11.2 Dr. Reddy Major Business
2.11.3 Dr. Reddy Drug Repositioning Product and Solutions
2.11.4 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dr. Reddy Recent Developments and Future Plans
2.12 R-Pharma
2.12.1 R-Pharma Details
2.12.2 R-Pharma Major Business
2.12.3 R-Pharma Drug Repositioning Product and Solutions
2.12.4 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 R-Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Repositioning Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Drug Repositioning by Company Revenue
3.2.2 Top 3 Drug Repositioning Players Market Share in 2023
3.2.3 Top 6 Drug Repositioning Players Market Share in 2023
3.3 Drug Repositioning Market: Overall Company Footprint Analysis
3.3.1 Drug Repositioning Market: Region Footprint
3.3.2 Drug Repositioning Market: Company Product Type Footprint
3.3.3 Drug Repositioning Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Repositioning Consumption Value and Market Share by Type (2019-2024)
4.2 Global Drug Repositioning Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Repositioning Consumption Value Market Share by Application (2019-2024)
5.2 Global Drug Repositioning Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Drug Repositioning Consumption Value by Type (2019-2030)
6.2 North America Drug Repositioning Consumption Value by Application (2019-2030)
6.3 North America Drug Repositioning Market Size by Country
6.3.1 North America Drug Repositioning Consumption Value by Country (2019-2030)
6.3.2 United States Drug Repositioning Market Size and Forecast (2019-2030)
6.3.3 Canada Drug Repositioning Market Size and Forecast (2019-2030)
6.3.4 Mexico Drug Repositioning Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Drug Repositioning Consumption Value by Type (2019-2030)
7.2 Europe Drug Repositioning Consumption Value by Application (2019-2030)
7.3 Europe Drug Repositioning Market Size by Country
7.3.1 Europe Drug Repositioning Consumption Value by Country (2019-2030)
7.3.2 Germany Drug Repositioning Market Size and Forecast (2019-2030)
7.3.3 France Drug Repositioning Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Drug Repositioning Market Size and Forecast (2019-2030)
7.3.5 Russia Drug Repositioning Market Size and Forecast (2019-2030)
7.3.6 Italy Drug Repositioning Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Repositioning Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Drug Repositioning Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Drug Repositioning Market Size by Region
8.3.1 Asia-Pacific Drug Repositioning Consumption Value by Region (2019-2030)
8.3.2 China Drug Repositioning Market Size and Forecast (2019-2030)
8.3.3 Japan Drug Repositioning Market Size and Forecast (2019-2030)
8.3.4 South Korea Drug Repositioning Market Size and Forecast (2019-2030)
8.3.5 India Drug Repositioning Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Drug Repositioning Market Size and Forecast (2019-2030)
8.3.7 Australia Drug Repositioning Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Drug Repositioning Consumption Value by Type (2019-2030)
9.2 South America Drug Repositioning Consumption Value by Application (2019-2030)
9.3 South America Drug Repositioning Market Size by Country
9.3.1 South America Drug Repositioning Consumption Value by Country (2019-2030)
9.3.2 Brazil Drug Repositioning Market Size and Forecast (2019-2030)
9.3.3 Argentina Drug Repositioning Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Repositioning Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Drug Repositioning Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Drug Repositioning Market Size by Country
10.3.1 Middle East & Africa Drug Repositioning Consumption Value by Country (2019-2030)
10.3.2 Turkey Drug Repositioning Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Drug Repositioning Market Size and Forecast (2019-2030)
10.3.4 UAE Drug Repositioning Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Drug Repositioning Market Drivers
11.2 Drug Repositioning Market Restraints
11.3 Drug Repositioning Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Repositioning Industry Chain
12.2 Drug Repositioning Upstream Analysis
12.3 Drug Repositioning Midstream Analysis
12.4 Drug Repositioning Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Drug Repositioning
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Repositioning by Type
1.3.1 Overview: Global Drug Repositioning Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Drug Repositioning Consumption Value Market Share by Type in 2023
1.3.3 Generic Drugs
1.3.4 Clinical Trial Failed Drugs
1.4 Global Drug Repositioning Market by Application
1.4.1 Overview: Global Drug Repositioning Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cardiovascular Diseases
1.4.3 Mental Illness
1.4.4 Cancer
1.4.5 Others
1.5 Global Drug Repositioning Market Size & Forecast
1.6 Global Drug Repositioning Market Size and Forecast by Region
1.6.1 Global Drug Repositioning Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Drug Repositioning Market Size by Region, (2019-2030)
1.6.3 North America Drug Repositioning Market Size and Prospect (2019-2030)
1.6.4 Europe Drug Repositioning Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Drug Repositioning Market Size and Prospect (2019-2030)
1.6.6 South America Drug Repositioning Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Drug Repositioning Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Drug Repositioning Product and Solutions
2.1.4 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Teva Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Drug Repositioning Product and Solutions
2.2.4 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Drug Repositioning Product and Solutions
2.3.4 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Drug Repositioning Product and Solutions
2.4.4 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Drug Repositioning Product and Solutions
2.5.4 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Drug Repositioning Product and Solutions
2.6.4 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bausch Health Recent Developments and Future Plans
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Drug Repositioning Product and Solutions
2.7.4 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSK Recent Developments and Future Plans
2.8 ChemRar Group
2.8.1 ChemRar Group Details
2.8.2 ChemRar Group Major Business
2.8.3 ChemRar Group Drug Repositioning Product and Solutions
2.8.4 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ChemRar Group Recent Developments and Future Plans
2.9 Glenmark
2.9.1 Glenmark Details
2.9.2 Glenmark Major Business
2.9.3 Glenmark Drug Repositioning Product and Solutions
2.9.4 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Glenmark Recent Developments and Future Plans
2.10 Fujifilm
2.10.1 Fujifilm Details
2.10.2 Fujifilm Major Business
2.10.3 Fujifilm Drug Repositioning Product and Solutions
2.10.4 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fujifilm Recent Developments and Future Plans
2.11 Dr. Reddy
2.11.1 Dr. Reddy Details
2.11.2 Dr. Reddy Major Business
2.11.3 Dr. Reddy Drug Repositioning Product and Solutions
2.11.4 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dr. Reddy Recent Developments and Future Plans
2.12 R-Pharma
2.12.1 R-Pharma Details
2.12.2 R-Pharma Major Business
2.12.3 R-Pharma Drug Repositioning Product and Solutions
2.12.4 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 R-Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Repositioning Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Drug Repositioning by Company Revenue
3.2.2 Top 3 Drug Repositioning Players Market Share in 2023
3.2.3 Top 6 Drug Repositioning Players Market Share in 2023
3.3 Drug Repositioning Market: Overall Company Footprint Analysis
3.3.1 Drug Repositioning Market: Region Footprint
3.3.2 Drug Repositioning Market: Company Product Type Footprint
3.3.3 Drug Repositioning Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Repositioning Consumption Value and Market Share by Type (2019-2024)
4.2 Global Drug Repositioning Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Repositioning Consumption Value Market Share by Application (2019-2024)
5.2 Global Drug Repositioning Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Drug Repositioning Consumption Value by Type (2019-2030)
6.2 North America Drug Repositioning Consumption Value by Application (2019-2030)
6.3 North America Drug Repositioning Market Size by Country
6.3.1 North America Drug Repositioning Consumption Value by Country (2019-2030)
6.3.2 United States Drug Repositioning Market Size and Forecast (2019-2030)
6.3.3 Canada Drug Repositioning Market Size and Forecast (2019-2030)
6.3.4 Mexico Drug Repositioning Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Drug Repositioning Consumption Value by Type (2019-2030)
7.2 Europe Drug Repositioning Consumption Value by Application (2019-2030)
7.3 Europe Drug Repositioning Market Size by Country
7.3.1 Europe Drug Repositioning Consumption Value by Country (2019-2030)
7.3.2 Germany Drug Repositioning Market Size and Forecast (2019-2030)
7.3.3 France Drug Repositioning Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Drug Repositioning Market Size and Forecast (2019-2030)
7.3.5 Russia Drug Repositioning Market Size and Forecast (2019-2030)
7.3.6 Italy Drug Repositioning Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Repositioning Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Drug Repositioning Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Drug Repositioning Market Size by Region
8.3.1 Asia-Pacific Drug Repositioning Consumption Value by Region (2019-2030)
8.3.2 China Drug Repositioning Market Size and Forecast (2019-2030)
8.3.3 Japan Drug Repositioning Market Size and Forecast (2019-2030)
8.3.4 South Korea Drug Repositioning Market Size and Forecast (2019-2030)
8.3.5 India Drug Repositioning Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Drug Repositioning Market Size and Forecast (2019-2030)
8.3.7 Australia Drug Repositioning Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Drug Repositioning Consumption Value by Type (2019-2030)
9.2 South America Drug Repositioning Consumption Value by Application (2019-2030)
9.3 South America Drug Repositioning Market Size by Country
9.3.1 South America Drug Repositioning Consumption Value by Country (2019-2030)
9.3.2 Brazil Drug Repositioning Market Size and Forecast (2019-2030)
9.3.3 Argentina Drug Repositioning Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Repositioning Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Drug Repositioning Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Drug Repositioning Market Size by Country
10.3.1 Middle East & Africa Drug Repositioning Consumption Value by Country (2019-2030)
10.3.2 Turkey Drug Repositioning Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Drug Repositioning Market Size and Forecast (2019-2030)
10.3.4 UAE Drug Repositioning Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Drug Repositioning Market Drivers
11.2 Drug Repositioning Market Restraints
11.3 Drug Repositioning Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Repositioning Industry Chain
12.2 Drug Repositioning Upstream Analysis
12.3 Drug Repositioning Midstream Analysis
12.4 Drug Repositioning Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Drug Repositioning Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drug Repositioning Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Drug Repositioning Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Drug Repositioning Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Teva Company Information, Head Office, and Major Competitors
Table 6. Teva Major Business
Table 7. Teva Drug Repositioning Product and Solutions
Table 8. Teva Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Teva Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Drug Repositioning Product and Solutions
Table 13. Novartis Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Mylan Company Information, Head Office, and Major Competitors
Table 16. Mylan Major Business
Table 17. Mylan Drug Repositioning Product and Solutions
Table 18. Mylan Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Mylan Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Drug Repositioning Product and Solutions
Table 23. Johnson & Johnson Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Drug Repositioning Product and Solutions
Table 28. Pfizer Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Bausch Health Company Information, Head Office, and Major Competitors
Table 31. Bausch Health Major Business
Table 32. Bausch Health Drug Repositioning Product and Solutions
Table 33. Bausch Health Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bausch Health Recent Developments and Future Plans
Table 35. GSK Company Information, Head Office, and Major Competitors
Table 36. GSK Major Business
Table 37. GSK Drug Repositioning Product and Solutions
Table 38. GSK Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. GSK Recent Developments and Future Plans
Table 40. ChemRar Group Company Information, Head Office, and Major Competitors
Table 41. ChemRar Group Major Business
Table 42. ChemRar Group Drug Repositioning Product and Solutions
Table 43. ChemRar Group Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. ChemRar Group Recent Developments and Future Plans
Table 45. Glenmark Company Information, Head Office, and Major Competitors
Table 46. Glenmark Major Business
Table 47. Glenmark Drug Repositioning Product and Solutions
Table 48. Glenmark Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Glenmark Recent Developments and Future Plans
Table 50. Fujifilm Company Information, Head Office, and Major Competitors
Table 51. Fujifilm Major Business
Table 52. Fujifilm Drug Repositioning Product and Solutions
Table 53. Fujifilm Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Fujifilm Recent Developments and Future Plans
Table 55. Dr. Reddy Company Information, Head Office, and Major Competitors
Table 56. Dr. Reddy Major Business
Table 57. Dr. Reddy Drug Repositioning Product and Solutions
Table 58. Dr. Reddy Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Dr. Reddy Recent Developments and Future Plans
Table 60. R-Pharma Company Information, Head Office, and Major Competitors
Table 61. R-Pharma Major Business
Table 62. R-Pharma Drug Repositioning Product and Solutions
Table 63. R-Pharma Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. R-Pharma Recent Developments and Future Plans
Table 65. Global Drug Repositioning Revenue (USD Million) by Players (2019-2024)
Table 66. Global Drug Repositioning Revenue Share by Players (2019-2024)
Table 67. Breakdown of Drug Repositioning by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Drug Repositioning, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Drug Repositioning Players
Table 70. Drug Repositioning Market: Company Product Type Footprint
Table 71. Drug Repositioning Market: Company Product Application Footprint
Table 72. Drug Repositioning New Market Entrants and Barriers to Market Entry
Table 73. Drug Repositioning Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Drug Repositioning Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Drug Repositioning Consumption Value Share by Type (2019-2024)
Table 76. Global Drug Repositioning Consumption Value Forecast by Type (2025-2030)
Table 77. Global Drug Repositioning Consumption Value by Application (2019-2024)
Table 78. Global Drug Repositioning Consumption Value Forecast by Application (2025-2030)
Table 79. North America Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Drug Repositioning Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Drug Repositioning Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Drug Repositioning Raw Material
Table 110. Key Suppliers of Drug Repositioning Raw Materials
Table 1. Global Drug Repositioning Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drug Repositioning Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Drug Repositioning Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Drug Repositioning Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Teva Company Information, Head Office, and Major Competitors
Table 6. Teva Major Business
Table 7. Teva Drug Repositioning Product and Solutions
Table 8. Teva Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Teva Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Drug Repositioning Product and Solutions
Table 13. Novartis Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Mylan Company Information, Head Office, and Major Competitors
Table 16. Mylan Major Business
Table 17. Mylan Drug Repositioning Product and Solutions
Table 18. Mylan Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Mylan Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Drug Repositioning Product and Solutions
Table 23. Johnson & Johnson Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Pfizer Company Information, Head Office, and Major Competitors
Table 26. Pfizer Major Business
Table 27. Pfizer Drug Repositioning Product and Solutions
Table 28. Pfizer Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Pfizer Recent Developments and Future Plans
Table 30. Bausch Health Company Information, Head Office, and Major Competitors
Table 31. Bausch Health Major Business
Table 32. Bausch Health Drug Repositioning Product and Solutions
Table 33. Bausch Health Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bausch Health Recent Developments and Future Plans
Table 35. GSK Company Information, Head Office, and Major Competitors
Table 36. GSK Major Business
Table 37. GSK Drug Repositioning Product and Solutions
Table 38. GSK Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. GSK Recent Developments and Future Plans
Table 40. ChemRar Group Company Information, Head Office, and Major Competitors
Table 41. ChemRar Group Major Business
Table 42. ChemRar Group Drug Repositioning Product and Solutions
Table 43. ChemRar Group Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. ChemRar Group Recent Developments and Future Plans
Table 45. Glenmark Company Information, Head Office, and Major Competitors
Table 46. Glenmark Major Business
Table 47. Glenmark Drug Repositioning Product and Solutions
Table 48. Glenmark Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Glenmark Recent Developments and Future Plans
Table 50. Fujifilm Company Information, Head Office, and Major Competitors
Table 51. Fujifilm Major Business
Table 52. Fujifilm Drug Repositioning Product and Solutions
Table 53. Fujifilm Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Fujifilm Recent Developments and Future Plans
Table 55. Dr. Reddy Company Information, Head Office, and Major Competitors
Table 56. Dr. Reddy Major Business
Table 57. Dr. Reddy Drug Repositioning Product and Solutions
Table 58. Dr. Reddy Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Dr. Reddy Recent Developments and Future Plans
Table 60. R-Pharma Company Information, Head Office, and Major Competitors
Table 61. R-Pharma Major Business
Table 62. R-Pharma Drug Repositioning Product and Solutions
Table 63. R-Pharma Drug Repositioning Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. R-Pharma Recent Developments and Future Plans
Table 65. Global Drug Repositioning Revenue (USD Million) by Players (2019-2024)
Table 66. Global Drug Repositioning Revenue Share by Players (2019-2024)
Table 67. Breakdown of Drug Repositioning by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Drug Repositioning, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Drug Repositioning Players
Table 70. Drug Repositioning Market: Company Product Type Footprint
Table 71. Drug Repositioning Market: Company Product Application Footprint
Table 72. Drug Repositioning New Market Entrants and Barriers to Market Entry
Table 73. Drug Repositioning Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Drug Repositioning Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Drug Repositioning Consumption Value Share by Type (2019-2024)
Table 76. Global Drug Repositioning Consumption Value Forecast by Type (2025-2030)
Table 77. Global Drug Repositioning Consumption Value by Application (2019-2024)
Table 78. Global Drug Repositioning Consumption Value Forecast by Application (2025-2030)
Table 79. North America Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Drug Repositioning Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Drug Repositioning Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Drug Repositioning Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Drug Repositioning Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Drug Repositioning Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Drug Repositioning Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Drug Repositioning Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Drug Repositioning Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Drug Repositioning Raw Material
Table 110. Key Suppliers of Drug Repositioning Raw Materials
LIST OF FIGURES
Figure 1. Drug Repositioning Picture
Figure 2. Global Drug Repositioning Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drug Repositioning Consumption Value Market Share by Type in 2023
Figure 4. Generic Drugs
Figure 5. Clinical Trial Failed Drugs
Figure 6. Global Drug Repositioning Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Drug Repositioning Consumption Value Market Share by Application in 2023
Figure 8. Cardiovascular Diseases Picture
Figure 9. Mental Illness Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global Drug Repositioning Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Drug Repositioning Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Drug Repositioning Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Drug Repositioning Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Drug Repositioning Consumption Value Market Share by Region in 2023
Figure 17. North America Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Drug Repositioning Revenue Share by Players in 2023
Figure 23. Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Drug Repositioning Market Share in 2023
Figure 25. Global Top 6 Players Drug Repositioning Market Share in 2023
Figure 26. Global Drug Repositioning Consumption Value Share by Type (2019-2024)
Figure 27. Global Drug Repositioning Market Share Forecast by Type (2025-2030)
Figure 28. Global Drug Repositioning Consumption Value Share by Application (2019-2024)
Figure 29. Global Drug Repositioning Market Share Forecast by Application (2025-2030)
Figure 30. North America Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 40. France Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Drug Repositioning Consumption Value Market Share by Region (2019-2030)
Figure 47. China Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 50. India Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 64. Drug Repositioning Market Drivers
Figure 65. Drug Repositioning Market Restraints
Figure 66. Drug Repositioning Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Drug Repositioning in 2023
Figure 69. Manufacturing Process Analysis of Drug Repositioning
Figure 70. Drug Repositioning Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Drug Repositioning Picture
Figure 2. Global Drug Repositioning Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drug Repositioning Consumption Value Market Share by Type in 2023
Figure 4. Generic Drugs
Figure 5. Clinical Trial Failed Drugs
Figure 6. Global Drug Repositioning Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Drug Repositioning Consumption Value Market Share by Application in 2023
Figure 8. Cardiovascular Diseases Picture
Figure 9. Mental Illness Picture
Figure 10. Cancer Picture
Figure 11. Others Picture
Figure 12. Global Drug Repositioning Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Drug Repositioning Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Drug Repositioning Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Drug Repositioning Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Drug Repositioning Consumption Value Market Share by Region in 2023
Figure 17. North America Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Drug Repositioning Revenue Share by Players in 2023
Figure 23. Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Drug Repositioning Market Share in 2023
Figure 25. Global Top 6 Players Drug Repositioning Market Share in 2023
Figure 26. Global Drug Repositioning Consumption Value Share by Type (2019-2024)
Figure 27. Global Drug Repositioning Market Share Forecast by Type (2025-2030)
Figure 28. Global Drug Repositioning Consumption Value Share by Application (2019-2024)
Figure 29. Global Drug Repositioning Market Share Forecast by Application (2025-2030)
Figure 30. North America Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 40. France Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Drug Repositioning Consumption Value Market Share by Region (2019-2030)
Figure 47. China Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 50. India Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Drug Repositioning Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Drug Repositioning Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Drug Repositioning Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Drug Repositioning Consumption Value (2019-2030) & (USD Million)
Figure 64. Drug Repositioning Market Drivers
Figure 65. Drug Repositioning Market Restraints
Figure 66. Drug Repositioning Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Drug Repositioning in 2023
Figure 69. Manufacturing Process Analysis of Drug Repositioning
Figure 70. Drug Repositioning Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
